Ana Pedrero Gil/LinkedIn
Jul 24, 2026, 04:53
Ana Pedrero Gil: The Future of Blood-Derived Therapies
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Kerstin Wendland et al., published in Transfusion Medicine and Hemotherapy, adding:
“Donated blood is no longer used only as standard transfusion components but is increasingly being developed into new types of therapies.
This review explains recent progress in turning plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood into more advanced medical products.”
Title: From Donation to Innovation: New Blood-Derived Products
Authors: Kerstin Wendland, Kathleen Selleng, Konstanze Aurich
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia